Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AREN NASDAQ:SMTK NASDAQ:SSC NASDAQ:VSEE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARENThe Arena Group$6.63+1.8%$6.19$0.56▼$10.05$314.70M0.61182,275 shs279,638 shsSMTKSmartKem$0.65$0.92$0.59▼$7.80$2.95M3.36107,913 shs57,046 shsSSCIdeanomics$0.01$30,061.20$1.41▼$7.00$731K2.12413,565 shs1,234 shsVSEEVSee Health$0.82-5.7%$1.16$0.62▼$3.54$2.95MN/A389,992 shs40,185 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARENThe Arena Group+1.09%-2.84%+2.04%-3.41%+615.31%SMTKSmartKem-2.23%+8.33%-35.00%-51.13%-87.96%SSCIdeanomics0.00%-33.33%0.00%-60.00%-96.15%VSEEVSee Health+4.82%+1.09%-38.30%-20.18%-50.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARENThe Arena Group2.4596 of 5 stars3.50.00.00.02.03.30.0SMTKSmartKem0.628 of 5 stars0.05.00.00.01.90.00.0SSCIdeanomicsN/AN/AN/AN/AN/AN/AN/AN/AVSEEVSee Health1.5599 of 5 stars2.04.00.00.01.50.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARENThe Arena Group 3.00Buy$12.0081.00% UpsideSMTKSmartKem 0.00N/AN/AN/ASSCIdeanomics 0.00N/AN/AN/AVSEEVSee Health 4.00Strong Buy$5.00509.76% UpsideCurrent Analyst Ratings BreakdownLatest SSC, AREN, VSEE, and SMTK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/15/2025ARENThe Arena GroupLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$10.00 ➝ $12.007/21/2025ARENThe Arena GroupLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.00(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARENThe Arena Group$146.61M2.15N/AN/A($2.48) per share-2.67SMTKSmartKem$80K36.89N/AN/A($0.03) per share-21.67SSCIdeanomics$144.34M0.01N/AN/A$0.48 per share0.02VSEEVSee HealthN/AN/AN/AN/A($3.40) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARENThe Arena Group-$55.58M$2.61N/A∞N/A-70.59%N/A-15.23%N/ASMTKSmartKem-$10.33M-$2.68N/A∞N/AN/A-321.41%-172.10%N/ASSCIdeanomics-$9.83MN/A0.00∞N/A-5.37%-72.38%-19.27%N/AVSEEVSee Health-$4.41MN/A0.00∞N/AN/AN/AN/A9/22/2025 (Estimated)Latest SSC, AREN, VSEE, and SMTK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025SMTKSmartKemN/A-$0.30N/A-$0.30N/A$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARENThe Arena GroupN/AN/AN/AN/AN/ASMTKSmartKemN/AN/AN/AN/AN/ASSCIdeanomicsN/AN/AN/AN/AN/AVSEEVSee HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARENThe Arena GroupN/A0.150.15SMTKSmartKemN/A0.860.86SSCIdeanomicsN/A1.161.16VSEEVSee HealthN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARENThe Arena Group85.55%SMTKSmartKemN/ASSCIdeanomics1.67%VSEEVSee Health1.01%Insider OwnershipCompanyInsider OwnershipARENThe Arena Group74.20%SMTKSmartKem8.70%SSCIdeanomics40.40%VSEEVSee Health6.59%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARENThe Arena Group36047.47 million12.25 millionOptionableSMTKSmartKem294.54 million4.15 millionN/ASSCIdeanomicsN/A73.14 millionN/ANot OptionableVSEEVSee HealthN/A3.60 million3.37 millionN/ASSC, AREN, VSEE, and SMTK HeadlinesRecent News About These CompaniesVSee Health, Inc. (NASDAQ:VSEE) Sees Significant Decrease in Short InterestAugust 18, 2025 | americanbankingnews.comVSee Health Appeals NASDAQ Staff Delisting NoticeAugust 12, 2025 | accessnewswire.comAVSee Health stock plummets as Nasdaq delisting loomsAugust 11, 2025 | au.investing.comCORRECTING and REPLACING VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911July 16, 2025 | businesswire.comVSee Health stock soars after launching AI doctor notes solutionJuly 14, 2025 | in.investing.comVSee Health Stock Jumps After Unveiling AI-Powered Doctor Notes ToolJuly 14, 2025 | msn.comVSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911July 14, 2025 | businesswire.comVSee Health ($VSEE): AI Telehealth Powerhouse Tapped for NIH Stroke Study as It Redefines the $787B Digital Healthcare MarketJune 26, 2025 | theglobeandmail.comVSee Health selected for NIH-funded stroke recovery telerehab trialJune 25, 2025 | investing.comVSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial - Business WireJune 24, 2025 | businesswire.comVSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical TrialJune 23, 2025 | businesswire.comVSee Health faces Nasdaq compliance issue over late filingsJune 1, 2025 | investing.comVSee Health faces Nasdaq delisting over late filingJune 1, 2025 | uk.investing.comVSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q FilingMay 30, 2025 | businesswire.comVSee Health launches telehealth initiative in the PhilippinesMay 17, 2025 | investing.comVSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote PhilippinesMay 16, 2025 | businesswire.comVSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K FilingMay 12, 2025 | businesswire.comVSee Health Inc. Faces Nasdaq Delisting Over Late FilingMay 10, 2025 | investing.comVSee Health unveils AI-driven telenursing platformApril 18, 2025 | uk.investing.comVSee Unveils Advanced Telenursing Robotics Solution Targeting 3-5% Reduction in Hospital Nursing CostsApril 16, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025Why the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025American Airlines Earnings Miss, But Bulls Aren’t Backing OffBy Gabriel Osorio-Mazilli | July 28, 2025Micron Stock Still Cheap Despite 25% Rally, Analysts SayBy Gabriel Osorio-Mazilli | August 19, 2025SSC, AREN, VSEE, and SMTK Company DescriptionsThe Arena Group NYSE:AREN$6.63 +0.12 (+1.84%) Closing price 04:00 PM EasternExtended Trading$6.60 -0.04 (-0.53%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Arena Group Holdings, Inc., together with its subsidiaries, operates digital media platform in the United States and internationally. The company offers the Platform, a proprietary online publishing platform comprising publishing tools, video platforms, social distribution channels, newsletter technology, machine learning content recommendations, notifications, and other technology. The company also offers content from individual creators to the HubPages network of premium content channels, such as PetHelpful, dengarden and Fashionista for writers, explorers, knowledge seekers, and conversation starters to connect in an interactive and informative online space under the HubPages brand. In addition, it operates the media business for Sports Illustrated brand. Further, the company owns and operates brands, including TheStreet, a financial news and information provider to investors and institutions, and produces business news and market analysis for individual investors; The Spun, an online independent sports publication; Parade, an entertainment coverage with stories and health content; and Men's Journal, a suite of digital assets that provides audience with access to premium active lifestyle brands. The company was formerly known as TheMaven, Inc. and changed its name to The Arena Group Holdings, Inc. in February 2022. The company is based in New York, New York. The Arena Group Holdings, Inc. operates as a subsidiary of Authentic Brands Group Inc.SmartKem NASDAQ:SMTK$0.65 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$0.66 +0.01 (+2.15%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SmartKem, Inc. develops electronics transistors using its proprietary advanced semiconductor materials. Its technology can be used in a range of applications including next generation MicroLED, LCD and AMOLED displays, as well as advanced computer and AI chip packaging, and a new type of sensor. The company was founded on September 21, 2018 and is headquartered in Blackley, the United Kingdom.Ideanomics NASDAQ:SSCIdeanomics, Inc. is a global company focused on facilitating the adoption of commercial electric vehicles and developing next generation financial services and Fintech product. The firm operates through the Mobile Energy Global (MEG) and Ideanomics Capital business units. Its electric vehicle division, MEG, provides group purchasing discounts on commercial electric vehicles, EV batteries and electricity, as well as financing and charging solutions. Ideanomics Capital includes DBOT ATS and Intelligenta, which provide financial services solutions powered by AI and blockchain. The company was founded by Shane B. McMahon on October 19, 2004 and is headquartered in New York, NY.VSee Health NASDAQ:VSEE$0.82 -0.05 (-5.75%) Closing price 03:47 PM EasternExtended Trading$0.83 +0.01 (+0.73%) As of 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot 3 Reasons Salesforce Is a Bargain Right Now Broadcom Named in Apple’s $100B U.S. Investment Plan Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.